Neurocrine Biosciences Inc (NBIX)
125.00
+1.71
(+1.39%)
USD |
NASDAQ |
Nov 21, 16:00
123.15
-1.85
(-1.48%)
After-Hours: 20:00
Neurocrine Biosciences Gross Profit Margin (Quarterly): 98.71% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 98.71% |
June 30, 2024 | 98.44% |
March 31, 2024 | 98.54% |
December 31, 2023 | 98.35% |
September 30, 2023 | 97.75% |
June 30, 2023 | 97.46% |
March 31, 2023 | 97.98% |
December 31, 2022 | 98.13% |
September 30, 2022 | 98.43% |
June 30, 2022 | 98.73% |
March 31, 2022 | 98.52% |
December 31, 2021 | 98.69% |
September 30, 2021 | 98.58% |
June 30, 2021 | 98.93% |
March 31, 2021 | 98.77% |
Date | Value |
---|---|
December 31, 2020 | 98.83% |
September 30, 2020 | 98.96% |
June 30, 2020 | 99.21% |
March 31, 2020 | 99.11% |
December 31, 2019 | 98.98% |
September 30, 2019 | 99.01% |
June 30, 2019 | 99.13% |
March 31, 2019 | 99.21% |
December 31, 2018 | 98.82% |
September 30, 2018 | 98.98% |
June 30, 2018 | 99.12% |
March 31, 2018 | 98.66% |
December 31, 2017 | 99.20% |
September 30, 2017 | 99.29% |
June 30, 2017 | 99.04% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
97.46%
Minimum
Jun 2023
99.21%
Maximum
Jun 2020
98.56%
Average
98.63%
Median
Gross Profit Margin (Quarterly) Benchmarks
Repligen Corp | 50.03% |
West Pharmaceutical Services Inc | 35.44% |
Bruker Corp | 48.45% |
The Cooper Companies Inc | 66.11% |
Integra Lifesciences Holdings Corp | 52.58% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 16.28% |
Return on Assets | 11.76% |
Return on Invested Capital | 15.50% |
Profit Margin (Quarterly) | 20.86% |
Operating Margin (Quarterly) | 29.71% |
Return on Net Operating Assets | 46.54% |